{
    "organizations": [],
    "uuid": "46e547033689c6b05cada0971b5788f00483564b",
    "author": "",
    "url": "https://www.reuters.com/article/brief-immunogen-says-on-jan-8-co-disclos/brief-immunogen-says-on-jan-8-co-disclosed-it-expects-to-report-that-as-of-dec-31-2017-it-had-cash-and-cash-equivalents-of-about-267-1-mln-idUSFWN1P30S5",
    "ord_in_thread": 0,
    "title": "BRIEF-Immunogen Says On Jan 8, Co Disclosed It Expects To Report That As Of Dec 31, 2017 It Had Cash And Cash Equivalents Of About $267.1 Mln",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "#Market News January 8, 2018 / 2:28 PM / in 13 minutes BRIEF-Immunogen Says On Jan 8, Co Disclosed It Expects To Report That As Of Dec 31, 2017 It Had Cash And Cash Equivalents Of About $267.1 Mln Reuters Staff 1 Min Read \nJan 8 (Reuters) - Immunogen Inc: \n* IMMUNOGEN SAYS ON JAN 8, CO DISCLOSED IT EXPECTS TO REPORT THAT AS OF DEC 31, 2017 IT HAD CASH AND CASH EQUIVALENTS OF ABOUT $267.1 MILLION - SEC FILING Source text ( bit.ly/2CRXR5Q ) Further company coverage:",
    "published": "2018-01-08T16:28:00.000+02:00",
    "crawled": "2018-01-08T16:53:48.019+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "market",
        "news",
        "january",
        "pm",
        "minute",
        "say",
        "jan",
        "co",
        "disclosed",
        "expects",
        "report",
        "dec",
        "cash",
        "cash",
        "equivalent",
        "mln",
        "reuters",
        "staff",
        "min",
        "read",
        "jan",
        "reuters",
        "immunogen",
        "inc",
        "immunogen",
        "say",
        "jan",
        "co",
        "disclosed",
        "expects",
        "report",
        "dec",
        "cash",
        "cash",
        "equivalent",
        "million",
        "sec",
        "filing",
        "source",
        "text",
        "company",
        "coverage"
    ]
}